Zydus Lifesciences Limited

ZYDUSLIFE.NS·NSE·Healthcare
Compare
1,129.40−5.60 (−0.49%)today
At close: Oct 23, 3:28 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,135.00
Open1,138.00
Day range1,118.901,143.50
52-week range835.501,232.10
Off day high−1.23%
Off 52-week high−8.34%
Volume1.50M
Avg. volume (3M)1.47M
Market cap1.13T
EPS (TTM)44.87
Forward P/E22.85
P/E ratio (TTM)25.17
Dividend yield0.09% (1.00)
Beta (5Y)0.37
Shares outstanding997.50M
Short interest—
Earnings dateNov 4, 2026
Analyst target1,210.29
Profit margin15.78%

Against its peers

Compare in full ›
ZYDUSLIFE.NS MANKIND.BO 009420.KS WOCKPHARMA.BO ZTS 1795.TW
Market cap 1.13T 915.72B 2.04T 292.69B 33.45B 45.96B
P/E (TTM) 25.2 44.9 — 71.5 13.3 12.1
Forward P/E 22.8 31.3 — — 12.6 7.3
Price/book 4.2 5.6 — 6.0 10.6 1.9
Dividend yield 0.09% — — — 2.59% 1.49%
1-year change +12.95% −6.37% +20.66% +39.52% −43.81% −38.58%
Today −0.49% −2.63% −0.25% −2.96% −1.29% −1.99%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

BusinessLine·Positive

Zydus Lifesciences gets USFDA nod for menopause treatment drug

Zydus Lifesciences Ltd on Wednesday said it has received the final approval from the US health regulator to market a generic transdermal system for treatment of moderate to severe symptoms of menopause and prevent postmenopausal…

HDFC Sky·Negative

Zydus Lifesciences Gets USFDA Approval for Hormone Patch

Authored By HDFC SKY | Published at: Oct 21, 2026 12:12 PM IST Zydus Lifesciences has received final USFDA approval for its estradiol and levonorgestrel transdermal system, which is eligible for 180-day Competitive Generic Therapy…

Medical Dialogues·Positive

Zydus Lifesciences' Moraiya Plant Receives 5 USFDA Observations

Ahmedabad: The US Food and Drug Administration (USFDA) has concluded an inspection of Zydus Lifesciences Limited's manufacturing plant at Moraiya in Ahmedabad, Gujarat, with five observations. The inspection was conducted from October 5 to…

Kalkine India·

Zydus Lifesciences Sri Lanka Plant: USD 20 Million JV Deal

Kalkine India Zydus Lifesciences (NSE:ZYDUSLIFE): Is It Building a Plant in Sri Lanka? Source: Krish Capital Pty Ltd Zydus Lifesciences Limited (NSE:ZYDUSLIFE) disclosed on 15 October 2026 that its proposed joint venture entity, Zydus…

scanx.trade·Positive

Zydus Lifesciences JV signs $20m Sri Lanka pharma facility deal

Zydus Lifesciences Limited, through its joint venture with Sunshine Healthcare, has signed an agreement with the Board of Investment (BOI) of Sri Lanka to establish a pharmaceutical manufacturing facility. The project involves a phased…

From articles in the 4Search news index.

In the news

27mentions in 30 days
27with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 27 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.